Journal
MABS
Volume 9, Issue 5, Pages 801-811Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/19420862.2017.1316914
Keywords
Antibody-drug conjugate (ADC); ion mobility-mass spectrometry (IM-MS); middle level; native mass spectrometry; site-specific bioconjugation; top level
Categories
Funding
- Region Alsace
- Communaute Urbaine de Strasbourg
- CNRS
- Universite de Strasbourg
- Agence Nationale de la Recherche (ANR)
- French Proteomic Infrastructure (ProFI) [ANR-10-INBS-08-03]
- GIS IBiSA
- Institut de Recherche Servier
- Syndivia
Ask authors/readers for more resources
Antibody-drug conjugates (ADCs) have emerged as a family of compounds with promise as efficient immunotherapies. First-generation ADCs were generated mostly via reactions on either lysine side-chain amines or cysteine thiol groups after reduction of the interchain disulfide bonds, resulting in heterogeneous populations with a variable number of drug loads per antibody. To control the position and the number of drug loads, new conjugation strategies aiming at the generation of more homogeneous site-specific conjugates have been developed. We report here the first multi-level characterization of a site-specific ADC by state-of-the-art mass spectrometry (MS) methods, including native MS and its hyphenation to ion mobility (IM-MS). We demonstrate the versatility of native MS methodologies for site-specific ADC analysis, with the unique ability to provide several critical quality attributes within one single run, along with a direct snapshot of ADC homogeneity/heterogeneity without extensive data interpretation. The capabilities of native IM-MS to directly access site-specific ADC conformational information are also highlighted. Finally, the potential of these techniques for assessing an ADC's heterogeneity/homogeneity is illustrated by comparing the analytical characterization of a site-specific DAR4 ADC to that of first-generation ADCs. Altogether, our results highlight the compatibility, versatility, and benefits of native MS approaches for the analytical characterization of all types of ADCs, including site-specific conjugates. Thus, we envision integrating native MS and IM-MS approaches, even in their latest state-of-the-art forms, into workflows that benchmark bioconjugation strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available